A report describes a personal account in which a patient says weight-loss injections did not help initially and she believed she would remain obese. The article states that after taking her first dose of Wegovy, she expected weight loss but instead felt the treatment was not working for her. The piece then says she was later diagnosed with a condition described as “often missed,” after which she was able to lose weight, reporting a loss of three stone. The article also highlights that the condition is presented as relatively common and that readers may recognize it through specific signs. However, the excerpt provided does not specify the medical condition, the diagnostic details, or the exact symptoms cited. Nor does it provide clinical evidence comparing outcomes with or without diagnosis, or comment on broader effectiveness of Wegovy in the wider population. Overall, the coverage centers on an individual experience linking delayed or incomplete response to weight-loss medication with a subsequent diagnosis of an underlying condition and subsequent weight loss after that diagnosis.